CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancer

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Oncogene

• Publication date

  2004-11-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1207914PMID 15378027
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Early Occurrence of RASSF1A Hypermethylation and Its Mutual Exclusion with BRAF Mutation in Thyroid Tumorigenesis

  2004influential reference
• Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients.

  2003cited by this paper
• RAS oncogenes: the first 30 years

  2003cited by this paper
• The Pro-apoptotic Ras Effector Nore1 May Serve as a Ras-regulated Tumor Suppressor in the Lung*

  2003cited by this paper
• NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers

  2003influential reference
• Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma

  2003cited by this paper
• Epigenetic Regulation of a Novel Tumor Suppressor Gene (hDAB2IP) in Prostate Cancer Cell Lines* 210

  2003influential reference
• Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma

  2003cited by this paper
• BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC

  2003cited by this paper
• The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1

  2002cited by this paper
• Mutations of the BRAF gene in human cancer

  2002cited by this paper
• RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1

  2002cited by this paper
• Identification of a novel Ras-regulated proapoptotic pathway.

  2002cited by this paper
• K-ras mutations and RASSF1A promoter methylation in colorectal cancer

  2002cited by this paper
• Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status

  2002cited by this paper
• Focus on lung cancer.

  2002cited by this paper
• Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression.

  2001cited by this paper
• Isolation, characterization, and chromosome mapping of a human A-C1 Ha-Ras suppressor gene (HRASLS)

  2001cited by this paper
• The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis

  2001cited by this paper
• Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3

  2000cited by this paper
• Ras Uses the Novel Tumor Suppressor RASSF1 as an Effector to Mediate Apoptosis*

  2000cited by this paper
• Molecular Cloning and Biological Activity of a Novel Ha-Ras Suppressor Gene Predominantly Expressed in Skeletal Muscle, Heart, Brain, and Bone Marrow by Differential Display Using Clonal Mouse EC Cells, ATDC5*

  1999cited by this paper
• Identification of Nore1 as a Potential Ras Effector*

  1998cited by this paper
• Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types

  1998cited by this paper
• The tumor suppressor protein p16INK4a.

  1997cited by this paper
• Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects

  1997cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996influential reference
• A novel family of Ras-binding domains.

  1996cited by this paper
• A novel family ofras-binding domains

  1996cited by this paper

• DNA methylation memory of pancreatic acinar-ductal metaplasia transition state altering Kras-downstream PI3K and Rho GTPase signaling in the absence of Kras mutation

  2025cites this paper
• The Epigenetic Hallmarks of Cancer.

  2024cites this paper
• Nore1 inhibits age-associated myeloid lineage skewing and clonal hematopoiesis but facilitates termination of emergency (stress) granulopoiesis

  2023cites this paper
• Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer Subtypes

  2022cites this paper
• Silencing effects of mutant RAS signalling on transcriptomes.

  2022cites this paper
• FusionAI: Predicting fusion breakpoint from DNA sequence with deep learning

  2021cites this paper
• Deep Learning Approach to Genomic Breakage Study from Primary Sequence

  2021cites this paper
• NORE1A directs apoptotic switch of TNF signaling through reciprocal modulation of ITCH-mediated destruction of TNFRI and BAX

  2020cites this paper
• CpG Islands in Cancer: Heads, Tails, and Sides.

  2018cites this paper
• Quantitative assessment of gene promoter methylation in non-small cell lung cancer using methylation-sensitive high-resolution melting

  2018cites this paper
• Ras signaling through RASSF proteins.

  2016cites this paper
• Decreased expression and aberrant methylation of RASSF5A correlates with malignant progression of gastric cardia adenocarcinoma

  2015cites this paper
• RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma

  2015cites this paper
• The role of RASSF 1 A methylation in cancer

  2014cites this paper
• Ras Effector Mutant Expression Suggest a Negative Regulator Inhibits Lung Tumor Formation

  2014influential citation
• NORE1A sensitises cancer cells to sorafenib-induced apoptosis and indicates hepatocellular carcinoma prognosis

  2014cites this paper
• Patho-Epigenetics of Disease

  2012cites this paper
• Epigenetic Reprogramming in Lung Carcinomas

  2012cites this paper
• The role of Bisphenol A in shaping the brain, epigenome and behavior.

  2011cites this paper
• Suppression of hydroxyurea-induced centrosome amplification by NORE1A and down-regulation of NORE1A mRNA expression in non-small cell lung carcinoma.

  2011cites this paper
• Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer.

  2011cites this paper
• Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer.

  2011cites this paper
• Epigenetic Changes in Cancer: Role of Environment

  2010cites this paper
• Epigenetic inactivation of the NORE1 gene correlates with malignant progression of colorectal tumors

  2010cites this paper
• Functional interaction of the Ras effector RASSF5 with the tyrosine kinase Lck: critical role in nucleocytoplasmic transport and cell cycle regulation.

  2010cites this paper
• Influències clíniques i ambientals en la prevalença de mutacions en l'oncogèn K-ras en pacients amb adenocarcinoma ductal de pàncrees

  2009cites this paper
• RASSF1A, BLU, NORE1A, PTEN and MGMT Expression and Promoter Methylation in Gliomas and Glioma Cell Lines and Evidence of Deregulated Expression of de novo DNMTs

  2009cites this paper
• Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.

  2009cites this paper
• Ras regulation of DNA-methylation and cancer.

  2008influential citation
• Molecular Alterations in Spontaneous Sputum of Cancer-Free Heavy Smokers: Results from a Large Screening Program

  2008cites this paper
• Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma.

  2008cites this paper
• DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update

  2008cites this paper
• DNA methylation‐mediated nucleosome dynamics and oncogenic Ras signaling

  2008cites this paper
• Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma

  2008cites this paper
• Gene methylation in pleural mesothelioma: correlations with clinico-pathological features and patient's follow-up.

  2008cites this paper
• Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer

  2008cites this paper
• The RASSF1A tumor suppressor

  2007influential citation
• Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma.

  2007cites this paper
• The Ras-association domain family (RASSF) members and their role in human tumourigenesis

  2007cites this paper
• The Role of RASSF1A Methylation in Cancer

  2007cites this paper
• Evaluation of the 3p21.3 tumour-suppressor gene cluster

  2007cites this paper
• RASSF1A methylation and K-ras and B-raf mutations and recurrent endometrial cancer.

  2007cites this paper
• Molecular analysis of a multistep lung cancer model induced by chronic inflammation reveals epigenetic regulation of p16 and activation of the DNA damage response pathway.

  2007cites this paper
• RASSF 1 A methylation and Kras and B-raf mutations and recurrent endometrial cancer

  2007cites this paper
• Nore1 and RASSF1 regulation of cell proliferation and of the MST1/2 kinases.

  2006cites this paper
• Identification of the Rassf3 gene as a potential tumor suppressor responsible for the resistance to mammary tumor development in MMTV/neu transgenic mice

  2006cites this paper
• Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.

  2006cites this paper
• RASSF2 Induces Activated Ras-Dependent Cell Growth Inhibition and Apoptosis in Human Pancreatic Cancer Cells

  2006cites this paper
• The Growth and Tumor Suppressor NORE1A Is a Cytoskeletal Protein That Suppresses Growth by Inhibition of the ERK Pathway*

  2006cites this paper
• RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI‐associated endometrial carcinoma

  2006cites this paper
• Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.

  2006cites this paper
• DNA methylation in normal colorectal in hyperplastic polyposis

  2006cites this paper
• Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis

  2006cites this paper
• Review The tumor suppressor RASSF1A in human carcinogenesis: an update

  2005cites this paper
• DNA methylation: its role in lung carcinogenesis and therapeutic implications

  2005cites this paper
• The tumor suppressor RASSF1A in human carcinogenesis: an update.

  2005cites this paper
• Aberrant DNA methylation as a cancer-inducing mechanism.

  2005cites this paper
• CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations

  2005cites this paper
• Dormant hypermethylated tumour suppressor genes: questions and answers

  2005cites this paper
• RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors

  2005cites this paper
• Role of the Ras-association domain family 1 tumor suppressor gene in human cancers.

  2005cites this paper